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The level of HTLV-I expression is low in vivo. We
found that recombinant interferon (IFN)-a and b
suppressed viral expression in HTLV-I-infected cells.
Non-lymphoid stromal cells also suppressed HTLV-I
expression through type-I IFNs. The suppression was
reversible after isolation of infected cells from the source
of IFNs, mimicking the status of viral expression in
freshly isolated ATL cells which is rapidly induced in
culture. Nevertheless, HTLV-I-infected individuals main-
tain acquired immune responses against HTLV-I such
as antibodies and cytotoxic T lymphocytes (CTLs), indi-
cating the presence of HTLV-I proteins in vivo. Analysis
on Tax-specific CTLs revealed that they were activated
in HAM/TSP but unresponsive in ATL patients. We
found that a subpopulation of HTLV-I carriers at
asymptomatic stage exhibited impaired Tax-specific
T-cell response and elevated HTLV-I proviral load. This
combination is a feature of ATL and likely to be an
underlying risk of ATL. Collectively, HTLV-I is doubly
controlled by acquired and innate immunity; HTLV-I-
specific CTLs eliminate infected cells, and IFNs suppress
viral expression. Both would contribute the reduction of
viral pathogenesis, while the efficiency of CTLs could be
partial because of limited viral expression. An increase
in viral expression would activate CTLs but also acceler-
ate inflammation. When the viral expression is well-con-
trolled, viral pathogenesis may not be apparent until
infected cell clones with a malignant phenotype finally
emerge, which may occur earlier without proper CTL
responses. Diversity in innate and acquired immune
responses among individuals might be important deter-
minants of disease manifestation in HTLV-I infection.
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